Table 2.
Treatment Groups | Baseline MFR | +Yoda1 MFR |
---|---|---|
Yoda1 Concentration (µM) | ||
1 | 6.5 ± 0.4 | 6.8 ± 0.2 |
5 | 5.7 ± 1.0 | 6.0 ± 1.0 |
10 | 2.4 ± 0.3 | 4.6 ± 0.6 * |
30 | 3.4 ± 0.5 | 14.3 ± 1.4 * |
50 | 2.4 ± 1.0 | 16.4 ± 2.5 * |
100 | 5.7 ± 1.0 | 15.0 ± 2.0 * |
DMSO (0.5%) | 3.3 ± 0.8 | 3.4 ± 0.5 |